Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome

被引：5

作者：

del-Pino, Rodrigo Aguirre ^{[1
,2
]}

Monahan, Rory C. ^{[1
,3
]}

Huizinga, Tom W. J. ^{[1
]}

Eikenboom, Jeroen ^{[4
]}

Steup-Beekman, Gerda M. ^{[1
,5
]}

机构：

[1] Leiden Univ Med Ctr, Dept Rheumatol, Leiden, Netherlands

[2] A Coruna Univ Hosp CHUAC, Div Rheumatol, Xubias Arriba 84, Galicia 15006, Spain

[3] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands

[4] Leiden Univ Med Ctr, Dept Internal Med, Div Thrombosis & Hemostasis, Leiden, Netherlands

[5] Haaglanden Med Ctr, Dept Rheumatol, The Hague, Netherlands

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2024年 / 50卷 / 06期

关键词：

antiphospholipid syndrome; antiphospholipid antibody; thrombosis; risk factor; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTICARDIOLIPIN ANTIBODIES; VENOUS THROMBOEMBOLISM; SYNDROME SCORE; FOLLOW-UP; VITAMIN-D; CLASSIFICATION CRITERIA; CARDIOVASCULAR-DISEASE; CLINICAL-SIGNIFICANCE; RHEUMATOID-ARTHRITIS;

D O I：

10.1055/s-0043-1776910

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Persistence of serum antiphospholipid antibodies (aPL) is associated with a high thrombotic risk, both arterial and venous, and with pregnancy complications. Due to the potential morbidity and mortality associated with the presence of aPL, identifying and recognizing risk factors for the development of aPL and thrombosis in aPL carriers may help to prevent and reduce the burden of disease. Multiple elements are involved in the pathomechanism of aPL development and aPL-related thrombosis such as genetics, malignancy, and infections. This review will address the role of both well-known risk factors and their evolution, and of emerging risk factors, including COVID-19, in the development of aPL and thrombosis in aPL carriers.

引用

页码：817 / 828

页数：12

共 50 条

[1] Beyond the "syndrome": Antiphospholipid antibodies as risk factors
Andreoli, Laura
Tincani, Angela
ARTHRITIS AND RHEUMATISM, 2012, 64 (02): : 342 - 345
[2] ANTIPHOSPHOLIPID ANTIBODIES AND ANTIPHOSPHOLIPID ANTIBODIES SYNDROME
GROB, JJ
BONERANDI, JJ
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1986, 113 (09): : 811 - 818
[3] ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME
ASHERSON, RA
CERVERA, R
GHARAVI, AE
ANNALES DE MEDECINE INTERNE, 1993, 144 (05): : 367 - 376
[4] ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME
HARRIS, EN
PIERANGELI, SS
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1994, 16 (2-3): : 223 - 245
[5] RISK FACTORS FOR PREGNANCY MORBIDITY IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES WITHOUT A DEFINED CLINICAL ANTIPHOSPHOLIPID SYNDROME
Demetrio Pablo, R.
Munoz, P.
Riancho-Zarrabeiti, L.
Calvo-Rio, V.
Lopez-Hoyos, M.
Martinez-Taboada, V.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S49 - S49
[6] RISK FACTORS FOR PREGNANCY MORBIDITY IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES WITHOUT A DEFINED CLINICAL ANTIPHOSPHOLIPID SYNDROME
Demetrio Pablo, R.
Munoz, P.
Riancho-Zarrabeitia, L.
Calvo-Rio, V.
Lopez-Hoyos, M.
Martinez-Taboada, V. M.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1067 - 1067
[7] Pediatric antiphospholipid antibodies and antiphospholipid syndrome
Hunt, Beverley J.
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (03): : 274 - 281
[8] Atherosclerosis, antiphospholipid syndrome, and antiphospholipid antibodies
Nicolo, Danielle
Varadhachary, Arun S.
Monestier, Marc
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 2171 - 2182
[9] Antiphospholipid antibodies in patients with antiphospholipid syndrome
Dodig, Slavica
Cepelak, Ivana
BIOCHEMIA MEDICA, 2024, 34 (02)
[10] Antiphospholipid antibodies and the antiphospholipid antibody syndrome
Nahass, GT
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (02) : 149 - 168

← 1 2 3 4 5 →